Head-to-head · Value Score
Vitara RX vs Royal Medical Center
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Royal Medical Center a 45. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameRoyal Medical Center
#389 · Grade C · Watch List
Est. first month
From $450/mo (2.5 mg dose, compounded)
Save ~67% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 45 — an est. $99/mo first month, with no teaser step-up baked in. Royal Medical Center isn't out of it: Shoppers who want credentialed MD founder with itemized dose-strength pricing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Royal Medical Center |
|---|---|---|
| Value Score | 91 (A) | 45 (C) |
| Est. first month | $99/mo | From $450/mo (2.5 mg dose, compounded) |
| Save vs brand-name | ~93% | ~67% |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | From $450/mo (2.5 mg dose, compounded) |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Royal Medical Center
Royal Medical Center is a physician-led nationwide telehealth practice centered on hormone therapy that also offers a compounded tirzepatide weight-loss program (no semaglutide).
Why it's a deal
- Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
- Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
- All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
- Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
- Florida physician with 30+ years of practice — a strong physician-led care signal
The fine print
- Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
- Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
- No LegitScript badge displayed
- States served not enumerated — site says 'nationwide' with no state list
- Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Royal Medical Center.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.